Bearish flow noted in Summit Therapeutics (SMMT) with 1,231 puts trading, or 1.6x expected. Most active are Oct-25 25 puts and Jan-26 15 puts, with total volume in those strikes near 890 contracts. The Put/Call Ratio is 2.46, while ATM IV is up over 1 point on the day. Earnings are expected on November 6th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMMT:
- Piper starts Summit Therapeutics with Neutral on high expectations
- Summit Therapeutics initiated with a Neutral at Piper Sandler
- Summit Therapeutics’ Promising Advancements in Cancer Treatment Drive Buy Rating
- Positive Outlook for Summit Therapeutics: Buy Rating Supported by Financial Stability and Strategic Developments
- Summit going concern language ‘non-issue,’ says Citi